CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 75 enrolled
Drug / intervention
Sublingual Sufentanil +1 moredrug
Likely dose
Sublingual Sufentanil 30 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04177862
NCT04177862Phase 4Completed
CompareCT.gov

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

University of Minnesota·interventional·Posted Nov 26, 2019·Updated Apr 19, 2021

In Brief

A Phase 4 clinical trial evaluating Sublingual Sufentanil and IV Fentanyl for Pain and 2 related conditions. Completed, enrolled 75 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if a single dose of sublingual sufentanil is as or more efficacious than a single dose of IV fentanyl in a post anesthesia care setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Pain, Acute, Anesthesia
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedNov 26, 2019
Enrollment StartDec 11, 2019
Primary CompletionJan 31, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.6 years ago

Interventions

Sublingual Sufentanildrug

30 mcg of sublingual sufentanil

IV Fentanyldrug

50 mcg of IV fentanyl